Point72 Hong Kong LTD Alnylam Pharmaceuticals, Inc. Transaction History

Point72 Hong Kong LTD

$1.35 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$146.51 - $198.2 $2.34 Million - $3.17 Million	15,971 New	15,971 $2.39 Million
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $6.17 Million - $10.3 Million	44,547 New	44,547 $8.92 Million
Q4 2021 Feb 14, 2022	SELL	$159.56 - $209.29 $622,284 - $816,231	-3,900 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$169.75 - $207.73 $589,032 - $720,823	3,470 Added 806.98%	3,900 $736,000
Q2 2021 Aug 16, 2021	BUY	$128.63 - $176.89 $55,310 - $76,062	430 New	430 $73,000
Q1 2021 May 17, 2021	SELL	$126.83 - $175.69 $57,453 - $79,587	-453 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$122.97 - $147.0 $15,863 - $18,963	-129 Reduced 22.16%	453 $59,000
Q3 2020 Nov 16, 2020	SELL	$121.19 - $165.49 $2.43 Million - $3.32 Million	-20,074 Reduced 97.18%	582 $85,000
Q2 2020 Aug 14, 2020	BUY	$104.21 - $156.44 $2.15 Million - $3.23 Million	20,656 New	20,656 $3.06 Million
Q1 2020 May 15, 2020	SELL	$93.12 - $133.99 $651 - $937	-7 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$74.51 - $124.23 $202,518 - $337,657	-2,718 Reduced 99.74%	7 $1,000
Q3 2019 Nov 14, 2019	SELL	$70.9 - $87.82 $38,498 - $47,686	-543 Reduced 16.62%	2,725 $219,000
Q2 2019 Aug 14, 2019	BUY	$65.86 - $92.79 $215,230 - $303,237	3,268 New	3,268 $237,000
Q4 2018 Feb 14, 2019	SELL	$62.67 - $88.33 $4,512 - $6,359	-72 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$87.52 - $122.67 $25,380 - $35,574	-290 Reduced 80.11%	72 $6,000
Q2 2018 Aug 14, 2018	BUY	$88.31 - $107.8 $31,968 - $39,023	362 New	362 $36,000
Q1 2018 May 15, 2018	SELL	$115.92 - $148.54 $127,512 - $163,394	-1,100 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$114.49 - $139.98 $64,114 - $78,388	560 Added 103.7%	1,100 $140,000
Q3 2017 Nov 14, 2017	BUY	$72.53 - $118.27 $39,166 - $63,865	540	540 $63,000

Others Institutions Holding ALNY

# of Institutions

645

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.22M

Capital World Investors Los Angeles, CA

16.5M
Shares

$4.4 Billion
0.73% of portfolio
Vanguard Group Inc Valley Forge, PA

12.6M
Shares

$3.37 Billion
0.06% of portfolio
Black Rock Inc. New York, NY

9.55M
Shares

$2.54 Billion
0.05% of portfolio
Capital Research Global Investors Los Angeles, CA

5.24M
Shares

$1.4 Billion
0.31% of portfolio
Wellington Management Group LLP Boston, MA

4.95M
Shares

$1.32 Billion
0.24% of portfolio

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $32.8B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.

Account